Abstract
Protein S (PS) is a vitamin K-dependent plasma glycoprotein. Around 60–70% of PS in plasma is noncovalently bound to C4-binding protein (C4BP). Free PS functions as a cofactor that enhances the activity of activated protein C (APC) in the proteolytic degradation of activated factors V and VIII. PS also has a more recently described APC-independent ability to directly inhibit prothrombinase and tenase by direct binding of activated factors V, VIII, and X.
Given that PS is one of the major naturally occurring inhibitors of coagulation, acquired or hereditary deficiencies of this protein result in excessive thrombin generation. As a vast array of mutations are responsible for hereditary PS deficiencies, screening for their presence by DNA testing would require sequencing each entire gene involving numerous exons. Moreover, the knowledge of the gene mutation does not offer any benefit in the treatment of thrombophilic families, so the routine molecular characterization is not indicative. These defects are detected by functional or immunological assays for free and total PS forms. Given that functional PS assays may detect some forms of PS deficiency that free PS immunoassays may miss, it is recommended to include them for initial testing along with immunoassays for free PS, although they should be used with caution. Functional PS assays are subject to multiple interference. For example in the presence of lupus anticoagulant (LA), only free PS immunoassays are recommended for initial testing. PS antigen assays are more popular with most laboratories.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Dahlback B, Hildebrand B, Malm J (1990) Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem 265:8127–8135
van Wijnen M, van’t Veer C, Stam JG et al (1996) The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S. Thromb Haemost 76:397–403
Koppelman SJ, van’t Veer C, Sixma JJ, Bouma BN (1995) Synergistic inhibition of the intrinsic factor X activation by protein S and C4b-binding protein. Blood 86:2653–2660
Fair DS, Marlar RA (1986) Biosynthesis and secretion of factor VII, protein C, protein S, and the protein C inhibitor from a human hepatoma cell line. Blood 67:64–70
Ogura M, Tanabe N, Nishioka J, Suzuki K, Saito H (1987) Biosynthesis and secretion of functional protein S by a human megakaryoblastic cell line (MEG-01). Blood 70:301–306
Malm J, He XH, Bjartell A, Shen L, Abrahamsson PA, Dahlback B (1994) Vitamin K-dependent protein S in Leydig cells of human testis. Biochem J 302(Pt 3):845–850
Gandrille S, Borgel D, Sala N et al (2000) Protein S deficiency: a database of mutations–summary of the first update. Thromb Haemost 84:918
Faioni EM, Franchi F, Asti D, Sacchi E, Bernardi F, Mannucci PM (1993) Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thromb Haemost 70:1067–1071
Jennings I, Kitchen S, Woods TA, Preston FE (2005) Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program. Semin Thromb Hemost 31:66–72
Laurell C (1977) Electroimmunoassay. Scand J Clin Lab Invest 29:21–37
Simmonds RE, Ireland H, Lane DA, Zoller B, de Frutos PG, Dahlback B (1998) Clarification of the risk for venous thrombosis associated with hereditary protein S deficiency by investigation of a large kindred with a characterized gene defect. Ann Intern Med 128:8–14
Makris M, Leach M, Beauchamp NJ et al (2000) Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood 95:1935–1941
Amiral J, Adalbert B, Adam M (1984) Application of enzyme immunoassays to coagulation testing. Clin Chem 30:1512–1516
Andrew M, Paes B, Milner R et al (1987) Development of the human coagulation system in the full-term infant. Blood 70:165–172
Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L (1992) Maturation of the hemostatic system during childhood. Blood 80:1998–2005
Monagle P, Barnes C, Ignjatovic V et al (2006) Developmental haemostasis–impact for clinical haemostasis laboratories. Thromb Haemost 95:362–372
Kottke-Marchant K, Comp P (2002) Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Arch Pathol Lab Med 126:1337–1348
Pabinger I, Allaart CF, Hermans J, Briet E, Bertina RM (1992) Hereditary protein C-deficiency: laboratory values in transmitters and guidelines for the diagnostic procedure. Report on a study of the SSC Subcommittee on Protein C and Protein S. Protein C Transmitter Study Group. Thromb Haemost 68:470–474
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Humana Press
About this protocol
Cite this protocol
Hepner, M., Karlaftis, V. (2013). Protein S. In: Monagle, P. (eds) Haemostasis. Methods in Molecular Biology, vol 992. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-339-8_30
Download citation
DOI: https://doi.org/10.1007/978-1-62703-339-8_30
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-338-1
Online ISBN: 978-1-62703-339-8
eBook Packages: Springer Protocols